Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
68pct
19d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Speak Out Act This bill prohibits the judicial enforceability of a predispute nondisclosure clause or predispute nondisparagement clause in a sexual assault dispute or sexual harassment dispute involving conduct that allegedly violates federal, tribal, or state law.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2022 · second_quarter · Consumer Issues/Safety/Products
Ordered to be Reported (Amended) by the Yeas and Nays: 22 - 13.
Committee Consideration and Mark-up Session Held.
Referred to the House Committee on the Judiciary.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
H.R. 963/ S. 505, Forced Arbitration Injustice Repeal Act (FAIR). H.R. 2195, Protecting the Employment Rights of Service Members Act (PERSA). H.R. 2196, Justice for Servicemembers Act. H.R. 2812, Fairness in Nursing Home Arbitration Act. H.R. 3947, bill to prohibit forced arbitration in health insurance contracts. S. 1334, PFAS Accountability Act. H.R. 2467, PFAS Action Act of 2021. H.R. 5169 / S. 2694, Nursing Home Improvement and Accountability Act. H.R. 4445 / S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021. H.R. 4350, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. H.R.4128, VALID Act of 2021. H.R. 7667, Food and Drug Amendments of 2022, with specific regard to provisions on cosmetics. H.R. 7900, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. HR 8227, SPEAK OUT Act. S. 4348, FDA Safety and Landmark Advancements Act. Draft legislation on prohibiting forced arbitration in age discrimination cases. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft cosmetics reform legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to COVID-19 liability. General lobbying on e-cigarettes safety and regulation. General lobbying on the FDA proposal regarding the testing of talc for asbestos. General lobbying on FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying on glyphosate safety. General lobbying on drug pricing.
Client expense: $1,010,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2022 · fourth_quarter · Torts
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 2617, Consolidated Appropriations Act, 2023, including potential amendments relating to Camp Lejeune litigation H.R. 4445/S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 H.R. 4777, Nondebtor Release Prohibition Act of 2021 H.R. 4841, Restoring Justice for Workers Act H.R. 6151, Highway Accident Fairness Act of 2021 H.R. 8227/S. 4524, Speak Out Act S. 742, Open and Responsive Government Act of 2021 S. 937, COVID-19 Hate Crimes Act S. 2428, False Claims Amendments Act of 2021 S. 3143, Resolving Sexual Assault and Harassment Disputes Act of 2021 Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); the use of arbitration to resolve disputes between federal contractors and their employees; decision making at independent agencies, White House interactions with independent agencies and Chevron deference; implementation of the Federal Arbitration Act (P.L. 68-401) and alternative dispute resolution mechanisms; legal reform; asbestos litigation; fraud and abuse in civil litigation
Client expense: $20,990,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2022 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 963/ S. 505, Forced Arbitration Injustice Repeal Act (FAIR). H.R. 2195, Protecting the Employment Rights of Service Members Act (PERSA). H.R. 2196, Justice for Servicemembers Act. H.R. 2812, Fairness in Nursing Home Arbitration Act. H.R. 3947, bill to prohibit forced arbitration in health insurance contracts. S. 1334, PFAS Accountability Act. H.R. 2467, PFAS Action Act of 2021. H.R. 5169 / S. 2694, Nursing Home Improvement and Accountability Act. H.R. 4445 / S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021. H.R. 4350, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. H.R.4128, VALID Act of 2021. H.R. 7667, Food and Drug Amendments of 2022, with specific regard to provisions on cosmetics. H.R. 7900, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. HR 8227/ S.4524, SPEAK OUT Act. S. 4348, FDA Safety and Landmark Advancements Act. H.R. 2617, Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. H.R. 9011, the Updated Drug labeling for Patient Safety Act. Draft legislation on fertility fraud. Draft legislation on prohibiting forced arbitration in age discrimination cases. Draft legislation on prohibiting forced arbitration in race discrimination cases. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft cosmetics reform legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to COVID-19 liability. General lobbying on e-cigarettes safety and regulation. General lobbying on the FDA proposal regarding the testing of talc for asbestos. General lobbying on FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying on glyphosate safety. General lobbying on drug pricing.
Client expense: $1,170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Labor Issues/Antitrust/Workplace
Issues related to H.R. 8227, The Speak Out Act.
Client expense: Not reported · Firm income: $50,000
Government targets: SENATE
2022 · fourth_quarter · Torts
Issues relating to nondisclosure agreements; USERRA Issues - Uniformed Services Employment and Reemployment Rights Act; H.R. 963, FAIR Act; H.R. 2025/S. 840, Litigation Funding Transparency Act of 2021; H.R. 3460, State Antitrust Enforcement Venue Act of 2021; H.R. 4445, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021; H.R. 7701, Wage Theft Prevention and Wage Recovery Act; H.R. 8227, Speak Out Act; S. 4524, Speak Out Act; Issues relating to litigation advertising; H.R. 7776, National Defense Authorization Act for Fiscal Year 2023 - Section 591 relating to The Service Members Civil Relief Act and Section 5205 relating to the Uniformed Services Employment and Reemployment Rights Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
S.4524/H.R.8227 - Speak Out Act to limit the judicial enforceability of a nondisclosure clause or nondisparagement clause agreed to before a dispute arises involving sexual assault or sexual harassment in violation of federal, tribal, or state law.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Labor Issues/Antitrust/Workplace
Issues related to H.R. 8227, The Speak Out Act.
Client expense: Not reported · Firm income: $50,000
Government targets: SENATE
2022 · third_quarter · Torts
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 4445/S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 H.R. 4777, Nondebtor Release Prohibition Act of 2021 H.R. 4841, Restoring Justice for Workers Act H.R. 6151, Highway Accident Fairness Act of 2021 H.R. 8227/S. 4524, Speak Out Act S. 742, Open and Responsive Government Act of 2021 S. 937, COVID-19 Hate Crimes Act S. 2428, False Claims Amendments Act of 2021 S. 3143, Resolving Sexual Assault and Harassment Disputes Act of 2021 Interim Final Rule, Request for Comments, Department of Justice; Guidelines and Limitations for Settlement Agreements Involving Payments to Non-Governmental Third Parties (87 Fed. Reg. 27,936- 27,938, May 10, 2022) Request for Comments, Administrative Conference of the United States; Disclosure of Agency Legal Materials (87 Fed. Reg. 30,445- 30,446, May 19, 2022) Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); the use of arbitration to resolve disputes between federal contractors and their employees; decisionmaking at independent agencies, White House interactions with independent agencies and Chevron deference; implementation of the Federal Arbitration Act (P.L. 68-401) and alternative dispute resolution mechanisms; legal reform; asbestos litigation; fraud and abuse in civil litigation
Client expense: $23,940,000 · Firm income: Not reported
2022 · third_quarter · Consumer Issues/Safety/Products
H.R. 963/ S. 505, Forced Arbitration Injustice Repeal Act (FAIR). H.R. 2195, Protecting the Employment Rights of Service Members Act (PERSA). H.R. 2196, Justice for Servicemembers Act. H.R. 2812, Fairness in Nursing Home Arbitration Act. H.R. 3947, bill to prohibit forced arbitration in health insurance contracts. S. 1334, PFAS Accountability Act. H.R. 2467, PFAS Action Act of 2021. H.R. 5169 / S. 2694, Nursing Home Improvement and Accountability Act. H.R. 4445 / S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021. H.R. 4350, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. H.R.4128, VALID Act of 2021. H.R. 7667, Food and Drug Amendments of 2022, with specific regard to provisions on cosmetics. H.R. 7900, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. HR 8227/ S.4524, SPEAK OUT Act. S. 4348, FDA Safety and Landmark Advancements Act. Draft legislation on fertility fraud. Draft legislation on prohibiting forced arbitration in age discrimination cases. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft cosmetics reform legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to COVID-19 liability. General lobbying on e-cigarettes safety and regulation. General lobbying on the FDA proposal regarding the testing of talc for asbestos. General lobbying on FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying on glyphosate safety. General lobbying on drug pricing.
2022 · third_quarter · Torts
Litigation reform measures generally Issues relating to nondisclosure agreements USERRA Issues - Uniformed Services Employment and Reemployment Rights Act H.R. 963, FAIR Act H.R. 2025/S. 840, Litigation Funding Transparency Act of 2021 H.R. 3460, State Antitrust Enforcement Venue Act of 2021 S. 2428, False Claims Amendments Act of 2021 S. 2429, Administrative False Claims Act of 2021 H.R. 4445, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 H.R. 7701, Wage Theft Prevention and Wage Recovery Act H.R. 8227, Speak Out Act S. 4524, Speak Out Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Law Enforcement/Crime/Criminal Justice
General litigation reform issues; H.R. 963/S. 505 - Forced Arbitration Injustice Repeal Act; S.4524/H.R. 8227 - Speak Out Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Torts
General litigation reform issues; H.R. 963/S. 505 - Forced Arbitration Injustice Repeal Act; S.4524/H.R. 8227 - Speak Out Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
H.R. 963/ S. 505, Forced Arbitration Injustice Repeal Act (FAIR). H.R. 2195, Protecting the Employment Rights of Service Members Act (PERSA). H.R. 2196, Justice for Servicemembers Act. H.R. 2812, Fairness in Nursing Home Arbitration Act. H.R. 3947, bill to prohibit forced arbitration in health insurance contracts. S. 1334, PFAS Accountability Act. H.R. 2467, PFAS Action Act of 2021. H.R. 5169 / S. 2694, Nursing Home Improvement and Accountability Act. H.R. 4445 / S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021. H.R. 4350, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. H.R.4128, VALID Act of 2021. H.R. 7667, Food and Drug Amendments of 2022, with specific regard to provisions on cosmetics. H.R. 7900, National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. HR 8227, SPEAK OUT Act. S. 4348, FDA Safety and Landmark Advancements Act. Draft legislation on prohibiting forced arbitration in age discrimination cases. Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft cosmetics reform legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to COVID-19 liability. General lobbying on e-cigarettes safety and regulation. General lobbying on the FDA proposal regarding the testing of talc for asbestos. General lobbying on FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying on glyphosate safety. General lobbying on drug pricing.
Client expense: $1,010,000 · Firm income: Not reported
2022 · second_quarter · Torts
H.R. 963/S. 505, Forced Arbitration Injustice Repeal (FAIR) Act H.R. 2453, Driving for Opportunity Act of 2021 H.R. 2547, Comprehensive Debt Collection Improvement Act H.R. 4445/S. 2342, Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021 H.R. 4777, Nondebtor Release Prohibition Act of 2021 H.R. 4841, Restoring Justice for Workers Act H.R. 6151, Highway Accident Fairness Act of 2021 H.R. 8227, To limit the judicial enforceability of predispute nondisclosure and nondisparagement contract clauses relating to disputes involving sexual assault and sexual harassment S. 742, Open and Responsive Government Act of 2021 S. 937, COVID-19 Hate Crimes Act S. 2428, False Claims Amendments Act of 2021 S. 3143, Resolving Sexual Assault and Harassment Disputes Act of 2021 Potential legislation similar to H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019 Various issues relating to COVID-19 liability relief; Servicemembers waiver of rights and protections under the Servicemembers Civil Relief Act (P.L. 108-189); the use of arbitration to resolve disputes between federal contractors and their employees; decisionmaking at independent agencies, White House interactions with independent agencies and Chevron deference; implementation of the Federal Arbitration Act (P.L. 68-401); alternative dispute resolution mechanisms; legal reform; asbestos litigation; fraud and abuse in civil litigation
Client expense: $15,800,000 · Firm income: Not reported
| Democratic |
| RI |
| Eleanor Holmes Norton | Democratic | DC |
| Gwen Moore | Democratic | WI |
| H. Morgan Griffith | Republican | VA |
| J. Luis Correa | Democratic | CA |
| Jerrold Nadler | Democratic | NY |
| John R. Curtis | Republican | UT |
| Kathy Castor | Democratic | FL |
| Ken Buck | Republican | CO |
| Maria Elvira Salazar | Republican | FL |
| Melanie A. Stansbury | Democratic | NM |
| Nikema Williams | Democratic | GA |
| Norma J. Torres | Democratic | CA |
| Pramila Jayapal | Democratic | WA |
| Robin L. Kelly | Democratic | IL |
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
Client expense: $1,180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)